Press Release

David P. King joins Truvian’s Advisory Board

Aspen Neuroscience Announces Completion of First and Second Cohorts in ASPIRO Phase 1/2a Trial for Parkinson’s Disease

Truvian Health Appoints Dr. Tina Nova to its Board of Directors

SonoThera Presents New Data at the American Society of Hematology (ASH) Annual Meeting Demonstrating the Potential of Targeted, Ultrasound-Mediated Gene Delivery to Liver

Nobias Therapeutics Announces Strategic Focus and New Leadership

Aspen Neuroscience Chief Financial Officer Kameel Farag to Present at UBS Global Healthcare Conference

Study PRO-101: Experience implementing an ALS community advisory board in early phase drug development

Aspen Neuroscience Announces Collaboration and License Agreement with Cell X Technologies

Aspen Neuroscience Chief Financial Officer Kameel Farag to Present at Upcoming Investor Conferences

Aspen Neuroscience Announces Dosing Completion of First Cohort in ASPIRO Phase 1/2a Trial for Parkinson’s Disease